Effect of Aqueous Extract of Garlic and Nystatin Mouthwash in Denture Stomatitis

NCT ID: NCT01198223

Last Updated: 2010-10-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-07-31

Study Completion Date

2010-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present study was to compare the effect of aqueous extract of garlic with nystatin mouthwash in denture stomatitis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Denture stomatitis is the most common form of chronic oral candidiasis manifested as chronic inflammation of the mucous membrane t supporting the movable prosthesis that may have a local or systemic nature. This inflammation is presented as mucous erythema and occasionally with pain and burning. The standard treatment for denture stomatitis is administration of nystatin which is accompanied with complications such as bitter taste as well as the high number of drug application that result in reduced tendency of patients in using this medication hence, efforts are continuously being made to substitute other types of therapies for this condition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Denture Stomatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

drug: garlic extract, nystatin

Drug: garlic extract 40mg/dl or nystatin suspension 100000 iu/ml tid for one month Patients had been clinically with denture stomatitis and confirmed by oral medicine specialist were selected for the study. Gender, age, medical history, erythema types, size, and other treatment used for this disease were recorded. Local ethical committee approval was obtained before the trial started and all patients gave written informed consent. Patients were randomly divided into two groups .First group received garlic extract and second group used nystatin suspension for 1 month. Each patients was examined at the beginning of the therapy ,and then every 1 weeks up to 1 months .

Group Type OTHER

garlic , nystatin

Intervention Type DRUG

mouthwash

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

garlic , nystatin

mouthwash

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

aquous garlic

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 40 years of age and older
* confirm of denture stomatitis by the oral medicine specialists

Exclusion Criteria

* Patients with a history of using anti-fungal drugs, antibiotics, and corticosteroid within the previous month
* allergy to garlic and nystatin mouthwash
* immunodeficiency
* uncontrolled diabetes
* those with garlic rich diet
* inability in using mouthwash
* loose and discolored dentures
* psychologic disorder and alzheimer
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Qazvin University Of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Qazvin University of Medical Science

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

mahin bakhshi, DDS,MS

Role: STUDY_CHAIR

Qazvin University of Medical Science

Jamileh bigom Taheri, DDS/MS

Role: STUDY_DIRECTOR

Shahid Beheshti University of Medical Science

Samira Basir Shabestari, DDS/MS

Role: PRINCIPAL_INVESTIGATOR

QUMS

Rozbeh Pahlevan, DDS

Role: PRINCIPAL_INVESTIGATOR

QUMS

Anet Tanic, DDS

Role: PRINCIPAL_INVESTIGATOR

QUMS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

QUMS

Qazvin, Qazvin Province, Iran

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Iran

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

QUMS 1234

Identifier Type: -

Identifier Source: org_study_id